Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | January 27, 2026 | January 29, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,160 |
Reported balance
After 2026-01-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 59,160 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,285 |
Reported balance
Holding disclosure · report date 2026-01-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,285 F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2: Includes units acquired through dividend investment since the last report filed by the reporting person.
QUEST DIAGNOSTICS INC
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,140 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 31,140 F1: Represents an award of restricted stock units. F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units.
F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,030.022 |
Reported balance
After 2017-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-15 · Gift · Disposed 935 · Balance 73,030.022 |
| Common StockSEC Table I · non-derivative | Direct | 67,498.022 |
Reported balance
After 2017-10-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-10-30 · Gift · Disposed 5,532 · Balance 67,498.022 |
| Common StockSEC Table I · non-derivative | Direct | 128,617.022 |
Reported balance
After 2017-12-29 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2017-12-29 · Grant · Acquired 61,119 · Balance 128,617.022 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Direct | 153,451.022 |
Reported balance
After 2017-12-29 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2017-12-29 · Grant · Acquired 24,834 · Balance 153,451.022 F3: Includes 24,834 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger. |
| Common StockSEC Table I · non-derivative | Direct | 153,451 |
Reported balance
After 2017-12-29 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2017-12-29 · Disposition to issuer · Disposed 0.022 · Balance 153,451 F4: Includes 0.022 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. |
| Common StockSEC Table I · non-derivative | Direct | 118,648 |
Reported balance
After 2017-12-29 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2017-12-29 · Disposition to issuer · Disposed 34,803 · Balance 118,648 F5: Includes 34,803 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 61,119 |
Reported balance
After 2017-12-29 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2017-12-29 · Disposition to issuer · Disposed 57,529 · Balance 61,119 F6: Includes 57,529 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2017-12-29 · Disposition to issuer · Disposed 61,119 · Balance 0 F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 0 |
Reported balance
After 2017-12-29 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2017-12-29 · Disposition to issuer · Disposed 3,928.794 · Balance 0 F7: Includes 3,928.794 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger. |
| Common StockSEC Table I · non-derivative | IndirectBy Children | 0 |
Reported balance
After 2017-12-29 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2017-12-29 · Disposition to issuer · Disposed 802 · Balance 0 F8: Includes 802 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. F9: The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $186.43 · Expires 2025-12-09 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-12-29 · Disposition to issuer · Disposed 65,857 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.87 · Expires 2024-12-10 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-12-29 · Disposition to issuer · Disposed 61,219 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.37 · Expires 2023-12-11 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-12-29 · Disposition to issuer · Disposed 65,385 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.69 · Expires 2022-12-12 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-12-29 · Disposition to issuer · Disposed 74,055 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $219.56 · Expires 2026-12-14 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-12-29 · Disposition to issuer · Disposed 50,929 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger.
F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
F3: Includes 24,834 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.
F4: Includes 0.022 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
F5: Includes 34,803 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.
F6: Includes 57,529 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.
F7: Includes 3,928.794 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger.
F8: Includes 802 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
F9: The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2022 Filed May 20, 2022 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000094 · wf-form4_165307903851442.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,933 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes approximately 407 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 306 | $135.45 Strike: $0.00 | $41,446.17 |
DisclosureSEC source: 0001022079-22-000066 · wf-form4_164910434883118.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,991.022 Underlying: Common Stock · 306 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 14:15 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001649 · form4.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,816 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 247 | $167.70 Strike: $0.00 | $41,420.67 |
DisclosureSEC source: 0001022079-22-000002 · wf-form4_164133222107425.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,631.404 Underlying: Common Stock · 247 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 288 | $143.77 Strike: $0.00 | $41,404.32 |
DisclosureSEC source: 0001022079-21-000135 · wf-form4_163346605371662.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,336.621 Underlying: Common Stock · 288 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 313 | $132.52 Strike: $0.00 | $41,478.76 |
DisclosureSEC source: 0001022079-21-000103 · wf-form4_162560376749724.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,999.945 Underlying: Common Stock · 313 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000095 · wf-form4_162197566755164.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,234 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 325.79 | $128.47 Strike: $0.00 | $41,852.61 |
DisclosureSEC source: 0001022079-21-000062 · wf-form4_161739615371653.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638.791 Underlying: Common Stock · 325.79 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 15:18 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000014 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,919 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 13:20 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 264 | $119.93 Strike: $0.00 | $31,662.31 |
DisclosureSEC source: 0001022079-21-000004 · wf-form4_161002559884422.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313.001 Underlying: Common Stock · 264 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:56 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 270 | $114.01 Strike: $0.00 | $30,782.70 |
DisclosureSEC source: 0001022079-20-000169 · wf-form4_160193133351771.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,005.111 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 203 | $113.73 Strike: $0.00 | $23,087.19 |
DisclosureSEC source: 0001022079-20-000144 · wf-form4_159372232940051.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,693.011 Underlying: Common Stock · 203 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 779 | $63.42 Strike: $63.42 | $49,404.18 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 15 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 779 shares Expires 2022-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 790 | $60.22 Strike: $60.22 | $47,569.85 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 14 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 790 shares Expires 2022-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $57.57 Strike: $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 13 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 820 | $61.62 Strike: $61.62 | $50,524.30 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 12 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 820 shares Expires 2022-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 151 | $58.37 Strike: $58.37 | $8,813.87 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 11 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 532 | $58.37 Strike: $58.37 | $31,052.84 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 10 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 532 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,547 | $57.74 Strike: $57.74 | $147,063.78 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 9 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,547 shares Expires 2021-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on December 6, 2012, the second on December 6, 2013 and the final on December 6, 2014. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 11,730 | $116.60 | $1,367,718.00 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 8 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,505 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 779 | $63.42 | $49,404.18 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 7 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 790 | $60.22 | $47,569.85 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 6 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,111 | $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 5 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 820 | $61.62 | $50,524.30 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 151 | $58.37 | $8,813.87 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 3 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 532 | $58.37 | $31,052.84 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 2 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 2,547 | $57.74 | $147,063.78 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000126 · wf-form4_159009364368927.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,505 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:04 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 403 | $76.55 Strike: $0.00 | $30,850.46 |
DisclosureSEC source: 0001022079-20-000093 · wf-form4_158594785447752.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433.781 Underlying: Common Stock · 403 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 18:25 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000019 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,078 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 291 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000004 · wf-form4_157808769545711.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987.831 Underlying: Common Stock · 291 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 18:16 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 7,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000002 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,278 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 288 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000173 · wf-form4_157004884330205.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,653.571 Underlying: Common Stock · 288 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 300 | $102.77 Strike: $0.00 | $30,829.50 |
DisclosureSEC source: 0001022079-19-000157 · wf-form4_156209927861595.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,320.961 Underlying: Common Stock · 300 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000133 · wf-form4_155803888989510.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,576 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 340 | $90.60 Strike: $0.00 | $30,804.00 |
DisclosureSEC source: 0001022079-19-000103 · wf-form4_155432372858523.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,971.681 Underlying: Common Stock · 340 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 14:03 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 107 | $246.58 | $26,384.06 |
DisclosureSEC source: 0001543407-19-000022 · edgar.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 18:39 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000014 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,305 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 376 | $82.00 Strike: $0.00 | $30,830.12 |
DisclosureSEC source: 0001022079-19-000004 · wf-form4_154655145311396.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585.231 Underlying: Common Stock · 376 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 19:01 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 13,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000001 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,382 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 14:32 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 42,000 | $237.07 | $9,956,940.00 |
DisclosureSEC source: 0001543407-18-000067 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,688 F1 · price: The reported sale price reflects the average sale price. Full information regarding sale price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| November 06, 2018 Filed Nov 7, 2018 14:56 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 116 | $230.50 | $26,738.00 |
DisclosureSEC source: 0001543407-18-000065 · edgar.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376 Underlying: Common Stock · 116 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 22:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 284 | $108.35 Strike: $0.00 | $30,769.98 |
DisclosureSEC source: 0001022079-18-000169 · wf-form4_153860691952801.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174.141 Underlying: Common Stock · 284 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 12:15 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 107 | $250.37 | $26,789.59 |
DisclosureSEC source: 0001543407-18-000054 · edgar.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 282 | $109.51 Strike: $0.00 | $30,881.82 |
DisclosureSEC source: 0001022079-18-000147 · wf-form4_153082247357083.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,860.281 Underlying: Common Stock · 282 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| July 02, 2018 Filed Jul 11, 2018 13:36 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 35,000 | $238.90 | $8,361,500.00 |
DisclosureSEC source: 0001543407-18-000052 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,688 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| May 16, 2018 Filed May 18, 2018 12:28 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under 1996 Directors Deferral Plan · Derivative | 115 | $224.22 | $25,785.30 |
DisclosureSEC source: 0001543407-18-000039 · edgar.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153 Underlying: Common Stock · 115 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000121 · wf-form4_152659275633400.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,496 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 313 | $98.54 Strike: $0.00 | $30,843.02 |
DisclosureSEC source: 0001022079-18-000098 · wf-form4_152287409191598.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,545.861 Underlying: Common Stock · 313 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 19:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 176 | $218.27 | $38,415.52 |
DisclosureSEC source: 0001543407-18-000029 · edgar.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Children Disclosed balance after: 231 F1 · shares: This sale is by the reporting person's child from amounts reported as indirectly owned. F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purpose of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.